Neurobiology of Khat (Catha Edulis Forsk)

Neglected Tropical Diseases and Conditions of the Nervous System

Volumn , Issue , 2014, Pages 307-319

  Patel, Nilesh B ^a  

^a UNIVERSITY OF NAIROBI   (Kenya)

Author keywords

Amphetamine; Cathinone; Drugs of abuse; Miraa; Psychostimulants; Qat

Indexed keywords

EID: 84926441165     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4614-8100-3_17     Document Type: Chapter

References (62)

1. Al-Motarreb A, Baker K, Broadley KJ (2002) Khat: pharmacological and medical aspects and its social use in Yemen. Phytother Res 16:403-413
2. Banjaw MY, Schmidt WJ (2005) Behavioural sensitization following repeated intermittent oral administration of Catha edulis in rats. Behav Brain Res 156:181-189
3. Banjaw MY, Fendt M, Schmidt WJ (2005) Clozapine attenuates the locomotor sensitisation and the prepulse inhibition deficit induced by a repeated oral administration of Catha edulis extract and cathinone in rats. Behav Brain Res 160:365-373
4. Banjaw MY, Miczek K, Schmidt WJ (2006) Repeated Catha edulis oral administration enhances the baseline aggressive behavior in isolated rats. J Neural Transm 113(5):543-556
5. Braendan OJ (1979) Research on the chemical composition of khat. NIDA Res Monogr 27:320-321
6. Calcagnetti DJ, Schechter MD (1992) Increases in the locomotor activity of rats after intracerebral administration of cathinone.Brain Res Bull 29:843-846
7. Calcagnetti DJ, Schechter MD (1992) Psychostimulant-induced activity is attenuated by two putative dopamine release inhibitors. Pharmacol Biochem Behav 43(4):1023-1031
8. Calcagnetti DJ, Schechter MD (1993) Place preference for the psychostimulant cathinone is blocked by pretreatment with a dopamine release inhibitor. Prog Neuropsychopharmacol Biol Psychiatry 17:637-649
9. Cleary L, Buber R, Docherty JR (2002) Effects of amphetamine derivatives and cathinone on noradrenaline-evoked contractions of rat right ventricle. Eur J Pharmacol 451(3):303-308
10. Connor JD, Rostom A, Makonnen E (2002) Comparison of effects khat extract and amphetamine on motor behaviors in mice. J Ethnopharmacol 8:65-71
11. Fleckenstein AE, Haughey HM, Metzger RR et al (1999) Differential effects of psychostimulants and related agents on dopaminergic and serotonergic transporter function. Eur J Pharmacol 382:45-49
12. Giannini AJ, Burge H, Shakeen M, Price WA (1986) Khat: another drug of abuse. J Psychoactive Drugs 18:155-158
13. Glennon RA, Liebowitz SM (1982) Serotonin receptor affinity of cathinone and related analogues. J Med Chem 25:393-397
14. Gosnell BA, Yracheta JM, Bell SM, Lane KE (1996) Intravenous self-administration of cathinone by rats. Behav Pharmacol 7:526-531
15. Goudie AJ, Atkinson J, West CR (1986) Discriminative properties of the psychostimulant dl-cathinone in a two lever operant task. Lack of evidence for dopaminergic mediation. Neuropharmacol 25:85-94
16. Halbach H (1979) Khat-the problem today. NIDA Res Monogr 27:318-319
17. Houghton P, Ismail M, Salvage S (2011) Not cathinone alone dopamine, khat constituents and brain tissue. http://darc-khat.middlesex.wikispaces.net/file/view/Not+cathinone+alone+_dopa mine+khat+constituents+and+brain+tissue+Houghton+et+al.pdf
18. Huang D, Wilson MC (1986) Comparative discriminative stimulus properties of dl-cathinone, d-amphetamine, and cocaine in rats. Pharmacol Biochem Behav 24(2):205-210
19. Kalix P (1980) Hypermotility of the amphetamine type induced by a constituent of khat leaves. Br J Pharmacol 68:11-13
20. Kalix P (1980) Hyperthermic response to cathinone, an alkaloid of Catha edulis (khat). J Pharm Pharmacol 32:662-663
21. Kalix P (1983) Effect of the alkaloid cathinone on the release of radioactivityfrom rabbit atria prelabelled with H-norepinephrine. Life Sci 32:801-807
22. Kalix P (1984) Effect of the alkaloid cathinone on the release of radioactivity from rat striatal tissue prelabelled with 3H-serotonin. Neuropsychobiology 12(2-3):127-129
23. Kalix P (1986) A comparison of the effects of some phenethylamines on the release of radioactivity from isolated rat caudate nucleus prelabelled with H dopamine. Arzneimittelforschung 36:1019-10121
24. Kalix P (1992) Cathinone, a natural amphetamine. Pharmacol Toxicol 70:77-86
25. Kalix P, Geisshusler S, Brenneisen R (1987) The effect of phenylpentenyl-khatamines on the release of radioactivity from rat striatal tissue prelabelled with dopamine. J Pharm Pharmacol 39:135-137
26. Kite GC, Ismail M, Simmonds MS, Houghton PJ (2003) Use of doubly protonated molecules in the analysis of cathedulins in crude extracts of khat (Catha edulis) by liquid chromatography/ serial mass spectrometry. Rapid Commun Mass Spectrom 17(14):1553-15564
27. Kuz’min AV, Evartan EE (1991) The intravenous self-administration of narcotics in mice. Zh Vyssh Nerv Deiat Im I P Pavlova 41:1253-1260
28. Magdum SS (2011) An overview of khat. Addict Disord Their Treat 10:72-83
29. Mereu GP, Pacitti C, Argiolas A (1983) Effect of cathinone, a khat leaf constituent, on dopaminergic firing and dopamine metabolism in the rat brain. Life Sci 32:1383-1389
30. Nutt D, King LA, Saulsbury W, Blakemore C (2007) Development of a rational scale to assess the harm of drugs to potential users. Lancet 369:1047-1053
31. Odenwald M (2014) Mental health problems associated with the use and abuse of khat (Catha edulis). In: Bentivoglio M, Cavalheiro EA, Kristensson K, Patel N (eds) Neglected tropical diseases and conditions of the nervous system. Springer, New York
32. Oyungu E, Kioy PG, Patel NB (2007) Effect of Catha edulis (khat) on behaviour and its potential to induce seizures in Sprague Dawley rats. East Afr Med J 84:219-22
33. Oyungu E, Kioy PG, Patel NB (2009) Proconvulsant effect of khat (Catha edulis) in Sprague- Dawley rats. J Ethnopharmacol 121:476-478
34. Pehek EA, Schechter MD, Yamamoto BK (1990) Effects of cathinone and amphetamine on the neurochemistry of dopamine in vivo. Neuropharmacology 29:1171-1176
35. Rosecrans JA, Campbell OL, Dewey WL, Harris LS (1979) Discriminative stimulus and neurochemical mechanism of cathinone: a preliminary study. NIDA Res Monogr 27:328-329
36. Saha S, Dollery C (2006) Severe ischaemic cardiomyopathy associated with khat chewing. J R Soc Med 99:316-318
37. Schechter MD (1986) Discriminative properties of l cathinone compared to dl- and dcathinone. Pharmacol Biochem Behav 24:1161-1165
38. Schechter MD (1986) Induction of and recovery from tolerance to the discriminative stimulus properties of l-cathinone. Pharmacol Biochem Behav 25:13-16
39. Schechter MD (1986) Dopaminergic mediation of a behavioral effect of l cathinone. Pharmacol Biochem Behav 25:337-340
40. Schechter MD (1989) Temporal parameters of cathinone, amphetamine and cocaine. Pharmacol Biochem Behav 34:289-292
41. Schechter MD (1990) Rats become acutely tolerant to cathine after amphetamine or cathinone administration. Psychopharmacology (Berl) 101:126-131
42. Schechter MD (1990) Dopaminergic nature of acute cathine tolerance. Pharmacol Biochem Behav 36:817-820
43. Schechter MD (1991) Effect of learned behavior upon conditioned place preference to cathinone. Pharmacol Biochem Behav 38:7-11
44. Schechter MD (1991) Effect of serotonin depletion by p chlorophenylalanine upon discriminative behaviours. Gen Pharmacol 22:889-8893
45. Schechter MD (1992) Effect of altering dopamine or serotonin neurotransmitters upon cathinone discrimination. Pharmacol Biochem Behav 41:37-41
46. Schechter MD, Bojaw W (1988) CGS 10746B is able to attenuate the effects of amphetamine: further evidence for dopaminergic mediation. Pharmacol Biochem Behav 30:1089-1092
47. Schechter MD, Glennon RA (1985) Cathinone, cocaine and methamphetamine: similarity of behavioral effects. Pharmacol Biochem Behav 22(6):913-916
48. Schechter MD, McBurney D (1991) Effect of repeated administrations upon cathinone discrimination and conditioned place preference. Gen Pharmacol 22:779-782
49. Schechter MD, Meehan SM (1993) Conditioned place preference produced by the psychostimulant cathinone. Eur J Pharmacol 232:135-138
50. Schechter MD, Rosecrans JA, Glennon RA (1984) Comparison of behavioral effects of cathinone, amphetamine and apomorphine. Pharmacol Biochem Behav 20:181-184
51. Schechter MD, Schechter JB, Calcagnetti DJ (1992) Direct microinjection of cathinone into the rat brain produces discriminative stimuli. Pharmacol Biochem Behav 42:619-623
52. Schmid CL, Bohn LM (2010) Serotonin, but not N-Methyltryptamines, activates the serotonin 2A receptor via a p-arrestin2/Src/Akt signaling complex in vivo. J Neurosci 30:13513-13524
53. Schorno X, Steinegger E (1978) The phyenylalkylamines of Catha edulis forsk: the absolute configuration of cathinone. United Nations Document MNAR/7/1978
54. Schuster CR, Johanson CE (1979) Behavioral studies of cathinone in monkeys and rats. NIDA Res Monogr 27:324-325
55. UNODC United Nations Office on Drugs and Crime (1980) Bulletin Narcotics (3)
56. Vollenweider FX (2001) Brain mechanism of hallucinogens and entactogens. Dialogues Clin Neurosci 3:265-279
57. Wagner GC, Preston K, Ricaurte GA, Schuster CR, Seiden LS (1982) Neurochemical similarities between d, l-cathinone and d-amphetamine. Drug Alcohol Depend 9:279-284
58. WHO Expert Committee on Addiction-Producing Drugs (1964) World Health Organization Technical Reprot Series No 273: pp 10
59. Wise RA, Bozarth MA (1987) A psychomotor stimulate theory of addiction. Psychol Rev 94:469-492
60. Woolverton WL, Johanson CE (1984) Preference in rhesus monkeys given a choice between cocaine and d, l cathinone. J Exp Anal Behav 41:35-43
61. Yanagita T (1979) Studies on cathinones: cardiovascular and behavioral effects in rats and selfadministration experiment in rhesus monkeys. NIDA Res Monogr 27:326-327
62. Yanagita T (1986) Intravenous self-administration of cathinone and 2-amino-1-(2,5 dimethoxy 4 methyl)phenylpropane in rhesus monkeys. Drug Alcohol Depend 17:135-141